Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Novel therapies for children with severe asthma
Top Ten Searches
hla beta 2 probiotics hypo allergenic scid urticaria aeroallergens asthma angioedema hivYour Article Summary
See Latest ArticlesEvidence for Humoral Rejection of a Pancreatic Islet Graft and Rescue with Rituximab and IV Immunoglobulin Therapy
American Journal of Transplantation, 06/16/09
Kessler L et al. - The authors describe the decline in islet function, in relation to HLA sensitization, in an islet transplant recipient and the recovery of this function after treatment with anti-CD20 monoclonal antibody and IV immunoglobulins. This immunization, already present in the pretransplant serum, had increased during the 6 months preceding the clinical deterioration. The search by ELISA for antibodies against HLA class II antigens became negative, the Luminex tests normalizing more gradually. As the result of an improvement in glucose control, the patient was again insulin-free.
Related Articles
Treatment of adult inflammatory myositis with rituximab: An emerging therapy for refractory patients
Journal of Clinical Rheumatology (JCR), 10/08/09
Relevance Score: 90%
Late onset Pneumocystis pneumonia in patients receiving rituximab for humoral renal transplant rejection
Nephrology, 10/07/09
Relevance Score: 89%
Prognostic significance of S-phase kinase-associated protein 2 and p27kip1 in patients with diffuse large B-cell lymphoma: Effects of rituximab
Annals of Oncology, 11/10/09
Relevance Score: 88%
Prevention of hepatitis B virus reactivation under rituximab therapy
Immunotherapy, 11/06/09
Relevance Score: 88%
Statin-independent prognosis of patients with diffuse large B-cell lymphoma receiving rituximab plus CHOP therapy
Annals of Oncology, 11/06/09
Relevance Score: 87%
Today in Gastrointestinal/Hepatic...keeping you current
Receive free subspecialty "5-minute updates" via email
Clinical factors predicting disease course in Crohn's disease
Expert Review of Clinical Immunology, 12/17/09
Differential requirements for IL-4/STAT6 signalling in CD4 T-cell fate determination and Th2-immune effector responses
Immunology & Cell Biology, 12/17/09
Mucosally induced Immunological Tolerance, Regulatory T Cells and the Adjuvant Effect by Cholera Toxin B Subunit
Scandinavian Journal of Immunology, 12/16/09
Today in Surgery/Transplantation...keeping you current
Receive free subspecialty "5-minute updates" via email
Improved 24-Hour Blood Pressure Control With Sirolimus Versus Calcineurin Inhibitor Based Immunosuppression in Renal Transplant Recipients
Transplantation Proceedings, 12/18/09
Foxp3 Staining in BK Virus Allograft Nephropathy and Comparison With Acute Cellular Rejection
Transplantation Proceedings, 12/18/09
Characteristics of Long-Term Immunosuppressive Therapy in Chinese Pediatric Renal Transplant Patients: A Single-Center Experience
Transplantation Proceedings, 12/18/09
Sponsor
Article Search
Sponsor
Sponsor